Effects of oleic acid on cell proliferation through an integrin-linked kinase signaling pathway in 786-O renal cell carcinoma cells

Liu,Zhenhua; Xiao,Yunbei; Yuan,Yeqing; Zhang,Xiaowei; Qin,Caipeng; Xie,Jing; Hao,Yichang; Xu,Tao; Wang,Xiaofeng

doi:10.3892/ol.2013.1160

Effects of oleic acid on cell proliferation through an integrin-linked kinase signaling pathway in 786-O renal cell carcinoma cells

Authors:
- Zhenhua Liu
- Yunbei Xiao
- Yeqing Yuan
- Xiaowei Zhang
- Caipeng Qin
- Jing Xie
- Yichang Hao
- Tao Xu
- Xiaofeng Wang
View Affiliations

Affiliations: Department of Urology, Peking University People's Hospital, Beijing 100044, P.R. China
Published online on: January 29, 2013 https://doi.org/10.3892/ol.2013.1160
Pages: 1395-1399

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increased risk of renal cell carcinoma (RCC) has been linked with obesity and metabolic syndrome. However, the mechanisms by which lipid metabolic disorders affect the development of RCC remain unclear and highly controversial. Integrin‑linked kinase (ILK) is a serine/threonine protein kinase involved in the regulation of tumor cell growth and angiogenesis. In the present study, the effect of free fatty acids in the promotion of RCC progression was investigated by upregulating ILK. Results of the MTT assay indicated that treatment of 786‑O cells with oleic acid induced a concentration‑dependent increase in cell viability. Flow cytometry analysis revealed that the effect of oleic acid on cell apoptosis was not significant. Following treatment with oleic acid, the expression of ILK, phospho‑Akt and G protein‑coupled receptor 40 (GPR40) was increased in 786‑O cells. These effects were reversed when the expression of ILK was downregulated using specific small interfering RNA. These results indicate that free fatty acids are associated with the development of renal cell carcinoma via activation of the GPR40/ILK/Akt pathway, revealing a novel mechanism for the correlation between metabolic disturbance and renal carcinoma.

View Figures

View References

1	Sourbier C and Massfelder T: Parathyroid hormone-related protein in human renal cell carcinoma. Cancer Lett. 240:170–182. 2006. View Article : Google Scholar : PubMed/NCBI
2	Schrader AJ, Varga Z, Hegele A, Pfoertner S, Olbert P and Hofmann R: Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches. J Cancer Res Clin Oncol. 132:137–149. 2006. View Article : Google Scholar : PubMed/NCBI
3	Tolle A, Jung M, Lein M, et al: Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer. 9:2482009. View Article : Google Scholar : PubMed/NCBI
4	Escudier B: Advanced renal cell carcinoma: current and emerging management strategies. Drugs. 67:1257–1264. 2007. View Article : Google Scholar : PubMed/NCBI
5	Habib SL, Prihoda TJ, Luna M and Werner SA: Diabetes and risk of renal cell carcinoma. J Cancer. 3:42–48. 2012. View Article : Google Scholar : PubMed/NCBI
6	Drabkin HA and Gemmill RM: Obesity, cholesterol and clear-cell renal cell carcinoma (RCC). Adv Cancer Res. 107:39–56. 2010. View Article : Google Scholar : PubMed/NCBI
7	Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Martinez-Orozco R and Salazar EP: Oleic acid promotes migration on MDA-MB-231 breast cancer cells through an arachidonic acid-dependent pathway. Int J Biochem Cell Biol. 42:306–317. 2010. View Article : Google Scholar : PubMed/NCBI
8	Suburu J and Chen YQ: Lipids and prostate cancer. Prostaglandins Other Lipid Mediat. 98:1–10. 2012. View Article : Google Scholar
9	Yun MR, Lee JY, Park HS, et al: Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/Akt signaling pathway. Pharmacol Res. 54:97–102. 2006. View Article : Google Scholar : PubMed/NCBI
10	Vinciguerra M, Carrozzino F, Peyrou M, et al: Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. 50:1132–1141. 2009. View Article : Google Scholar : PubMed/NCBI
11	Hannigan G, Troussard AA and Dedhar S: Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer. 5:51–63. 2005. View Article : Google Scholar : PubMed/NCBI
12	McDonald PC, Oloumi A, Mills J, et al: Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res. 68:1618–1624. 2008. View Article : Google Scholar : PubMed/NCBI
13	Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, Martinez-Orozco R and Salazar EP: Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin Exp Metastasis. 27:505–515. 2010. View Article : Google Scholar : PubMed/NCBI
14	Stemmer K, Perez-Tilve D, Ananthakrishnan G, et al: High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney. Dis Model Mech. 5:627–635. 2012. View Article : Google Scholar : PubMed/NCBI
15	Bartsch H, Nair J and Owen RW: Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis. 20:2209–2218. 1999. View Article : Google Scholar : PubMed/NCBI
16	Willett WC: Specific fatty acids and risks of breast and prostate cancer: dietary intake. Am J Clin Nutr. 66:1557S–1563S. 1997.PubMed/NCBI
17	Han S, Sun X, Ritzenthaler JD and Roman J: Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase. Mol Cancer Res. 7:108–117. 2009. View Article : Google Scholar : PubMed/NCBI
18	Hammamieh R, Chakraborty N, Miller SA, et al: Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 101:7–16. 2007. View Article : Google Scholar : PubMed/NCBI
19	Soto-Guzman A, Robledo T, Lopez-Perez M and Salazar EP: Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells. Mol Cell Endocrinol. 294:81–91. 2008. View Article : Google Scholar : PubMed/NCBI
20	Gorjao R, Hirabara SM, de Lima TM, Cury-Boaventura MF and Curi R: Regulation of interleukin-2 signaling by fatty acids in human lymphocytes. J Lipid Res. 48:2009–2019. 2007. View Article : Google Scholar : PubMed/NCBI
21	Persad S and Dedhar S: The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev. 22:375–384. 2003. View Article : Google Scholar : PubMed/NCBI
22	Del GS, Bugliani M, D’Aleo V, et al: G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids. Nutr Metab Cardiovasc Dis. 20:22–25. 2010. View Article : Google Scholar : PubMed/NCBI
23	Briscoe CP, Tadayyon M, Andrews JL, et al: The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 278:11303–11311. 2003. View Article : Google Scholar : PubMed/NCBI
24	Yonezawa T, Katoh K and Obara Y: Existence of GPR40 functioning in a human breast cancer cell line, MCF-7. Biochem Biophys Res Commun. 314:805–809. 2004. View Article : Google Scholar : PubMed/NCBI
25	Hardy S, St-Onge GG, Joly E, Langelier Y and Prentki M: Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem. 280:13285–13291. 2005. View Article : Google Scholar : PubMed/NCBI
26	Hanada M, Feng J and Hemmings BA: Structure, regulation and function of PKB/AKT - a major therapeutic target. Biochim Biophys Acta. 1697:3–16. 2004. View Article : Google Scholar : PubMed/NCBI
27	Dong LQ and Liu F: PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am J Physiol Endocrinol Metab. 289:E187–E196. 2005. View Article : Google Scholar : PubMed/NCBI